-transparent.png){kind=logo}
Neonatal chickens were injected intraventricularly with Ni(II), Pd(II), Cu(II) or Zn(II) complex of TRH and the potencies of stimulating locomotor activity were compared with that of TRH, Ni(II)-TRH was more potent than the ligand while Pd(II)-TRH was inert. Cu(II)- and Zn(II)-TRH induced the response to the same extent of the ligand. These results indicate that the action of TRH in the CNS resulting in the locomotor hyperactivity is dependent on the tertiary conformation of molecule which is modified by chelate formation.
Related Publications
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
January 1980,
The Journal of clinical endocrinology and metabolism,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
February 1979,
The Journal of pharmacology and experimental therapeutics,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
October 1983,
Regulatory peptides,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
February 2004,
Neuropeptides,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
January 1986,
Neuropeptides,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
January 1981,
Endocrinology,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
April 1985,
Neuropeptides,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
January 1988,
Clinical endocrinology,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
October 2003,
Bulletin of experimental biology and medicine,
T Tonoue, and
S Minagawa, and
N Kato, and
M Kan, and
T Terao, and
K Nonoyama, and
K Ohki
December 1985,
Orvosi hetilap,
